PD-1-ANTIKÖRPER

European patent · EP3411410 · In force

Register entry

Publication number
EP3411410
Application number
EP17746860
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 23, 2017
Published
Dec 12, 2018
Granted
Mar 10, 2021
Protection ends at the latest
Jan 22, 2037
Next annual fee due
Jan 31, 2027
IPC classes
C07K 16/28 (2006.01)
C12N 5/10 (2006.01)
A61K 39/395 (2006.01)
A61P 35/00 (2006.01)
Priority
WO PCT/CN2016/073169 02.02.2016
PCT application
PCT/CN2017/072190 23.01.2017
PCT publication
WO2017/133540 10.08.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  2. Feb 1, 2025

    Change

    Published in Swissreg on 01.02.2025

  3. Feb 1, 2024

    Change

    Published in Swissreg on 01.02.2024

  4. Feb 1, 2023

    Change

    Published in Swissreg on 01.02.2023

  5. Jan 19, 2022

    Change

    Published in Swissreg on 19.01.2022

  6. Mar 10, 2021

    Granted

    Published in Swissreg on 10.03.2021

Parties

Holder

Innovent Biologics (Suzhou) Co., Ltd.

168 Dongping Street Suzhou Industrial Park, Suzhou, Jiangsu 215123, CN

Inventor

LIU, Xiaolin

Jiangsu 215123, CN

TSUN, Andy

Jiangsu 215123, CN

YU, De-Chao Michael

Jiangsu 215123, CN

BARUAH, Hemanta

Jiangsu 215123, CN

CHEN, Cheng

Jiangsu 215123, CN

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.